LaNova Medicines’ License Agreement with Turning Point Therapeutics

Martina Bellini
Tagged:

Wilson Sonsini Goodrich & Rosati advised LaNova on the deal.Turning Point Therapeutics, Inc., a clinical-stage precision oncology company designing and developing novel targeted therapies for cancer…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

…

This content is for Standard 1 Year members only.
Login Join Now